Jess Perry
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
- Genetics 6
- Genetic Associations and Epidemiology 6
-
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 1
- Journals
- Nature (4 papers)The Lancet (2 papers)The Lancet Neurology (1 paper)Trials (1 paper)Human Genetics and Genomics Advances (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Jess Perry
10 papers receiving 1.2k citations
Jess Perry's Hit Papers
Peers
Comparison fields: 5 of 78
- Infectious Diseases 546
- Genetics 503
- Neurology 91
- Immunology 95
- Cardiology and Cardiovascular Medicine 53
Countries citing papers authored by Jess Perry
This map shows the geographic impact of Jess Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jess Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jess Perry more than expected).
Fields of papers citing papers by Jess Perry
This network shows the impact of papers produced by Jess Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jess Perry. The network helps show where Jess Perry may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 3 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 4 | 2021 | 79 | |
| 5 | 2022 | 74 | |
| 6 | 2023 | 60 | |
| 7 | 2024 | 27 | |
| 8 | 2024 | 8 | |
| 9 | 2023 | 6 | |
| 10 | 2025 | 5 | |
| 11 | 2021 | 0 |
About Jess Perry
Jess Perry is a scholar working on Genetics, Infectious Diseases, Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine, having authored 11 papers that have together received 1.3k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (6 papers), COVID-19 Clinical Research Studies (2 papers), Hemodynamic Monitoring and Therapy (1 paper), Prostate Cancer Treatment and Research (1 paper), Atrial Fibrillation Management and Outcomes (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Prostate Cancer Diagnosis and Treatment (1 paper) and Shoulder Injury and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (546 citations), Genetics (503 citations), Neurology (91 citations), Immunology (95 citations) and Cardiology and Cardiovascular Medicine (53 citations). Jess Perry has collaborated with scholars based in United Kingdom. Their work appears in journals such as Nature, The Lancet, The Lancet Neurology, Trials and Human Genetics and Genomics Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.